Literature DB >> 22974696

Safety of dabigatran versus warfarin for periprocedural anticoagulation in patients undergoing ablation for atrial fibrillation.

Roger A Winkle, R Hardwin Mead, Gregory Engel, Melissa H Kong, Rob A Patrawala.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22974696     DOI： 10.1016/j.jacc.2012.03.079

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  2 in total

Review 1.  Role of the new target specific oral anticoagulants in the management of anticoagulation for cardioversion and atrial fibrillation ablation.

Authors:  Marcin Kowalski; Valay Parikh
Journal:  J Thromb Thrombolysis       Date:  2013-08       Impact factor: 2.300

Review 2.  Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation.

Authors:  K Huber; S J Connolly; A Kher; F Christory; G-A Dan; R Hatala; R G Kiss; B Meier; B Merkely; B Pieske; T Potpara; J Stępińska; N Vene Klun; D Vinereanu; P Widimský
Journal:  Int J Clin Pract       Date:  2013-04-05       Impact factor: 2.503
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.